NECLIFE logo

Nectar Lifesciences LTD.

NECLIFE·NSE·
12.18 -0.36 (-2.87%)
Market Cap272.75 Cr
PE Ratio-1.00
Volume2,62,494
Day High - Low12.74 - 12.10
52W High-Low22.40 - 9.30
DocStoX Score
0.9/10
Poor
Fair Value
Sign in to see
ROE
-7.46%
Weak
P/E
-1.00x
Loss-making
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day12.10
12.74
52W9.30
22.40
DocStoX take

Supported by valuation (6.0), but held back by growth (0.0).

DocStoX score

Low confidence
0.9
/10
Poor
Quality
Weak
ROE -7.5%
Valuation
Fair
P/B 0.4× on assets (no earnings to value)
Growth
Flat
Revenue -73.5% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Weak
22% of 52-week range

At a glance

Market Cap
₹273 Cr
52W High / Low
₹22 / ₹9
Dividend Yield
0.00%
Promoter Holding
51.84%
EPS (TTM)
₹-15.08
Book Value
₹30.00

Key highlights

  • Low leverage — D/E 0.00
  • Loss-making — no meaningful P/E
  • Revenue shrinking 74% a year
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

NECTAR LIFESCIENCES LTD. peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.